Ryusuke Nishikawa

An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial

Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto et al. · Circulation · 2023 · 146 citations

Medicine, Cardiology, Pharmacotherapy +17

Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention

Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki et al. · Journal of the American College of Cardiology · 2023 · 62 citations

Medicine, Cardiology, Pharmacotherapy +12

Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial

Hirotoshi Watanabe, Masahiro Natsuaki, Takeshi Morimoto et al. · European Heart Journal · 2024 · 37 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Clinical outcomes and predictors of restenosis in patients with femoropopliteal artery disease treated using polymer-coated paclitaxel-eluting stents or drug-coated balloons

Naoki Yoshioka, Takahiro Tokuda, Akio Kôyama et al. · Heart and Vessels · 2021 · 29 citations

Medicine, Cardiology, Surgery +16

Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3)

Yukiko Matsumura‐Nakano, Hiroki Shiomi, Takeshi Morimoto et al. · The American Journal of Cardiology · 2021 · 26 citations

Medicine, Cardiology, Surgery +13